patient experience
Kyle Garcia
Kyle Garcia is fighting his brain tumor to be healthy enough for playtime with his four- and two-year-old sons, Max and Oliver.
“Cancer is not stopping me from cheering for my daughter”
Cancer hasn’t stopped Shelly Zaugg from traveling the US to see her daughter play softball. She has a team of support—on and off the diamond.
Marino DiRienzo
What does time well spent mean? For Marino DiRienzo, it’s simply another day spent with family.
Doc Sinclair
Family, music, rocks, fish — Doc Sinclair is a man of many passions. As he faces brain cancer, he strives to maintain an active, full life.
Janice Armbrust
Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day — one step — at a time.
Mike Hugo
Mike Hugo has packed a lot of life in his years, and he wants to teach his daughters to live with the same vigor and resolve.
Linda Long
Linda Long always saw the road ahead as she pursued her dream, making history in the Philadelphia Fire Department. Then she was diagnosed with glioblastoma.
Jovan Knutson
A glioblastoma diagnosis led Jovan Knutson to reevaluate what is most important to her. She has found joy in the moment, and with it, a renewed sense of purpose and resilience.
our culture
‘the courage of our patients inspired me to keep going’
Read how Yasushi ‘Joe’ Ishikawa from Novocure Japan overcame the challenge of running a 136 mile ultramarathon in the Bolivian mountains.
‘making our therapy accessible to patients motivates me’
Our colleagues’ passion for patients often leads to remarkable career paths. Read how Jana Meyer zu Drewer’s drive to make a difference in cancer guided her, from providing technical therapy support to our patients in Germany, to educating doctors about our therapy.
from hospitality to medtech
Because our mission of making a difference in cancer resonated deeply with her, Lea Pachur left her previous job as a hotel receptionist and joined us as a Management Assistant and Office Manager in our office in Munich.
unafraid to innovate
Katia Felix is not afraid to share her ideas. Throughout her career, she has paved a way for herself often by bringing her ideas to the table.
employee spotlight: Javier Beltran
Javier Beltran, Device Support Specialist, prioritizes being there for patients. He finds much satisfaction in giving patients a sense of empowerment over their cancer treatment.
working behind the scenes of our clinical trials
With her colleagues, Alice Chen, Associate Director, Clinical Trial Management, has been managing our clinical trials from beginning to completion.
‘we have the privilege to live our patient-forward mission’
Karin Gottwald’s passion for nursing was ignited at the age of nine. Today, she works for our company as a Senior Device Support Specialist with empathy and a smile.
enhancing awareness, scientific understanding of our therapy
Lamia Kalfane is determined to dedicate the remainder of her career to making the most significant difference possible in the lives of cancer patients.
features
Novocure joins New Hampshire Life Sciences
We will work with industry partners to champion New Hampshire’s cutting-edge life sciences sector and improve patients’ lives.
extra in the ordinary
Share stories of finding purpose and joy in simple moments while living with GBM.
you are not alone in facing a cancer diagnosis
Lean on patient advocacy groups for the support you need.
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
Novocure pledges $250K to Families First Health and Support Center
We committed the lead corporate gift to the capital campaign for a New Hampshire community health center’s new home.
lighting the world blue
Mesothelioma Awareness Day takes place annually in the U.S. on Sept. 26.
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
Ignace Vergote, Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.